Poly Medicure, also known as Poly Medicure Limited, is a leading player in the medical device industry, headquartered in India. Established in 1998, the company has made significant strides in the healthcare sector, particularly in the fields of infusion therapy, vascular access, and wound care. With a strong operational presence across Asia, Europe, and the Americas, Poly Medicure has positioned itself as a trusted provider of innovative medical solutions. The company’s core offerings include a diverse range of products such as intravenous catheters, blood transfusion sets, and surgical sutures, all designed with a focus on safety and efficacy. Poly Medicure is recognised for its commitment to quality and has achieved several certifications, enhancing its reputation in the global market. With a robust portfolio and a dedication to advancing healthcare, Poly Medicure continues to set benchmarks in the medical device industry.
How does Poly Medicure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Poly Medicure's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Poly Medicure reported total carbon emissions of approximately 36,820,130 kg CO2e, comprising 2,319,850 kg CO2e from Scope 1 and 33,962,280 kg CO2e from Scope 2 emissions. This data reflects the company's global operations, with no reported Scope 3 emissions. The previous year, 2023, saw similar emissions figures, indicating a consistent emission profile with 2,319,850 kg CO2e from Scope 1 and 33,962,280 kg CO2e from Scope 2. Poly Medicure has not set specific reduction targets or initiatives as part of its climate commitments, nor does it appear to have cascaded data from a parent organisation. The company has not disclosed any significant climate pledges or initiatives aimed at reducing its carbon footprint. Overall, while Poly Medicure's emissions data is available for the last two years, the absence of reduction targets suggests a need for enhanced climate action strategies in alignment with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | 2024 | |
---|---|---|---|
Scope 1 | 3,114,940 | 0,000,000 | 0,000,000 |
Scope 2 | 30,230,620 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Poly Medicure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.